Parenterals and injectables are the fastest growing dosage forms within the pharmaceutical industry, partially as a result of the uptick in orphan therapies, precision medicines, and biopharmaceutical drug products. Active pharmaceutical ingredients (APIs) are increasingly difficult to therapeutically deliver due to bioavailability issues and water insolubility, which often necessitates their administration as an injection.
LLS Health routinely develops and manufactures formulations for all routes of parenteral administration, including intravenous, subcutaneous, and intramuscular, within our
CDMO Division. We offer full-service drug product development and manufacturing services,
clinical and
commercial. We specialize in working with aseptically processed and more complex injectable dosage forms using a variety of formulation techniques, including nanomilled particulate systems and microparticle formulations.
